TL;DR:
- AIM-HI, part of Kaiser Permanente’s Division of Research, grants $750,000 each to five healthcare organizations.
- The grants are supported by the Gordon and Betty Moore Foundation.
- AIM-HI evaluates AI and ML applications for diagnostic decision-making in healthcare.
- Over 120 applications covering various AI and ML areas were assessed.
- Projects selected for their innovation in diverse technologies and patient groups.
- Recipients include doctors working on pediatric asthma, cardiac amyloidosis, sepsis resuscitation, diabetic retinopathy, and AI-enabled diagnosis.
- These transformative projects span three years, aiming to advance AI and ML in healthcare.
- AIM-HI provides support and shares best practices.
- Kaiser Permanente’s commitment to data-driven patient care is evident.
- This initiative empowers diverse healthcare organizations to explore AI and ML’s potential.
Main AI News:
In a groundbreaking move, the Kaiser Permanente Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) Coordinating Center, under the umbrella of the Kaiser Permanente Northern California Division of Research, is taking a significant stride towards transforming healthcare. Fueled by generous funding from the Gordon and Betty Moore Foundation, AIM-HI is granting up to $750,000 to five pioneering healthcare organizations, all dedicated to advancing artificial intelligence (AI) and machine learning (ML) in the realm of diagnostic decision-making.
With a keen focus on rigorously assessing the potential of AI and ML in healthcare, AIM-HI undertook the daunting task of evaluating over 120 applications, encompassing a wide spectrum of AI and ML applications, from predictive models to computer vision. Spearheaded by the visionary Dr. Vincent Liu, AIM-HI handpicked projects that promise innovative breakthroughs across a diverse range of technologies and patient demographics.
Let’s take a closer look at the exceptional recipients of these grants:
- Dr. Cesar Termulo, Jr., hailing from Parkland Health in Dallas, is channeling his efforts towards elevating pediatric asthma care within safety net health settings.
- Dr. David Ouyang, operating from The Smidt Heart Institute at Cedars-Sinai Medical Center in Los Angeles, is focused on identifying cardiac amyloidosis within diverse populations.
- Dr. Sivasubramanium Bhavani, representing Emory University in Atlanta, is pioneering precision sepsis resuscitation.
- Dr. Fatima Munoz, from San Ysidro Health in San Diego, is dedicated to enhancing diabetic retinopathy screening.
- Dr. Peter J. Embí, based at Vanderbilt University Medical Center in Nashville, is leading the charge in AI-enabled diagnosis.
These transformative projects, spanning a remarkable three-year timeline, are poised to push the boundaries of AI and ML applications in healthcare. The AIM-HI Coordinating Center, along with its distinguished Advisory Committee, will provide unwavering support and facilitate the exchange of best practices throughout this journey.
Conclusion:
Kaiser Permanente’s AIM-HI initiative is poised to revolutionize the healthcare market. By investing in cutting-edge AI and ML research, they are paving the way for transformative advancements in diagnostic decision-making. This not only strengthens Kaiser Permanente’s position as a leader in data-driven patient care but also sets a benchmark for the broader healthcare industry to harness the power of AI and ML in diverse settings, ultimately improving patient outcomes and driving innovation.
